Next Article in Journal
JNK-Bcl-2/Bcl-xL-Bax/Bak Pathway Mediates the Crosstalk between Matrine-Induced Autophagy and Apoptosis via Interplay with Beclin 1
Next Article in Special Issue
Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation
Previous Article in Journal
ClRTL1 Encodes a Chinese Fir RNase III–Like Protein Involved in Regulating Shoot Branching
Previous Article in Special Issue
Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection

Epidemiology of Hepatitis E Virus in European Countries

Laboratory of Virology, “Lazzaro Spallanzani” National Institute for Infectious Diseases, Via Portuense 292, Rome 00149, Italy
Author to whom correspondence should be addressed.
Academic Editor: Tatsuo Kanda
Int. J. Mol. Sci. 2015, 16(10), 25711-25743;
Received: 22 May 2015 / Revised: 12 September 2015 / Accepted: 16 October 2015 / Published: 27 October 2015
(This article belongs to the Special Issue Viral Hepatitis Research)
Over the last decade the seroprevalence of immunoglobulin (IgG) anti hepatitis E virus (HEV) has been increasing in European countries and shows significant variability among different geographical areas. In this review, we describe the serological data concerning the general population and risk groups in different European countries. Anti-HEV antibody prevalence ranged from 1.3% (blood donors in Italy) to 52% (blood donors in France). Various studies performed on risk groups in Denmark, Moldova and Sweden revealed that swine farmers have a high seroprevalence of HEV IgG (range 13%–51.1%), confirming that pigs represent an important risk factor in HEV infection in humans. Subtypes 3e,f are the main genotypes detected in the European population. Sporadic cases of autochthonous genotype 4 have been described in Spain, France, and Italy. Although most HEV infections are subclinical, in immune-suppressed and transplant patients they could provoke chronic infection. Fulminant hepatitis has rarely been observed and it was related to genotype 3. Interferon and ribavirin treatment was seen to represent the most promising therapy. View Full-Text
Keywords: hepatitis E virus; genotype; autochthonous; risk group hepatitis E virus; genotype; autochthonous; risk group
MDPI and ACS Style

Lapa, D.; Capobianchi, M.R.; Garbuglia, A.R. Epidemiology of Hepatitis E Virus in European Countries. Int. J. Mol. Sci. 2015, 16, 25711-25743.

AMA Style

Lapa D, Capobianchi MR, Garbuglia AR. Epidemiology of Hepatitis E Virus in European Countries. International Journal of Molecular Sciences. 2015; 16(10):25711-25743.

Chicago/Turabian Style

Lapa, Daniele, Maria R. Capobianchi, and Anna R. Garbuglia 2015. "Epidemiology of Hepatitis E Virus in European Countries" International Journal of Molecular Sciences 16, no. 10: 25711-25743.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop